rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to evaluate the safety and characteristics of live, recombinant viral vector vaccines. A recent publication by the V3SWG described live, attenuated, recombinant vesicular stomatitis virus (rVSV) as a chimeric vi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Vaccine X
Huvudupphovsmän: Monath, Thomas P., Fast, Patricia E., Modjarrad, Kayvon, Clarke, David K., Martin, Brian K., Fusco, Joan, Nichols, Richard, Heppner, D. Gray, Simon, Jakub K., Dubey, Sheri, Troth, Sean P., Wolf, Jayanthi, Singh, Vidisha, Coller, Beth-Ann, Robertson, James S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2019
Ämnen:
Brighton Collaboration
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668225/
https://ncbi.nlm.nih.gov/pubmed/31384731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvacx.2019.100009
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk